These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 10705228)

  • 1. Antibodies to HIV-1 gp41 recognize synthetic peptides of human IFN-alpha and IFN-beta.
    Bai Y; Zhao Y; Yu T; Dierich MP; Chen YH
    Int Arch Allergy Immunol; 2000 Feb; 121(2):170-2. PubMed ID: 10705228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies against human IFN-alpha and -beta recognized the immunosuppressive domain of HIV-1 gp41 and inhibit gp41-binding to the putative cellular receptor protein p45.
    Chen YH; Wu W; Yang J; Sui SF; Sun J; Dierich MP
    Immunol Lett; 1999 Aug; 69(2):253-7. PubMed ID: 10482360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased levels of antibodies against interferon-alpha in HIV-1 positive individuals may be explained by a common immunological epitope on the human interferon-alpha and HIV-1 gp41.
    Chen YH; Stoiber H; Dierich MP
    Immunol Lett; 1997 Jan; 55(1):15-8. PubMed ID: 9093876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 gp41 by a common immunological epitope induces increased levels of antibodies against human interferon-beta in HIV-1 positive individuals.
    Chen YH; Feng JN; Stöckl G; Hu K; Dierich MP
    Mol Immunol; 1997 Dec; 34(18):1259-62. PubMed ID: 9683267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A common immunological epitope existing between HIV-1 gp41 and human interferon-alpha and -beta.
    Chen YH; Dierich MP
    Immunobiology; 1998 Feb; 198(4):333-42. PubMed ID: 9562860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human interferon-beta inhibits binding of HIV-1 gp41 to lymphocyte and monocyte cells and binds the potential receptor protein P50 for HIV-1 gp41.
    Yu T; Xiao Y; Bai Y; Ru Q; Luo G; Dierich MP; Chen Y
    Immunol Lett; 2000 Jul; 73(1):19-22. PubMed ID: 10963806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 gp41 and type I interferon: sequence homology and biological as well as clinical implications.
    Chen YH; Xiao Y; Dierich MP
    Immunol Res; 2000; 22(1):61-6. PubMed ID: 10945227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV epitope-peptides in aluminum adjuvant induced high levels of epitope-specific antibodies.
    Tian H; Xiao Y; Zhu M; Chen YH
    Int Immunopharmacol; 2001 Apr; 1(4):763-8. PubMed ID: 11357888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of high levels of antibodies recognizing the neutralizing epitope ELDKWA and the D- or K-position-mutated epitopes by candidate epitope vaccines against HIV-1.
    Xiao Y; Dong X; Chen Y
    Int Arch Allergy Immunol; 2000 Aug; 122(4):287-92. PubMed ID: 10971120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A common epitope on gp41, IFN-alpha and IFN-beta induces protective activity.
    Chen YH; Dierich MP
    Immunol Today; 1998 Dec; 19(12):586-7. PubMed ID: 9864951
    [No Abstract]   [Full Text] [Related]  

  • 11. Antigenic activity of three chimeric synthetic peptides of the transmembrane (gp41) and the envelope (gp120) glycoproteins of HIV-1 virus.
    Marin MH; Peña LP; Tanty CR; Higginson Clarke D; Arenas MA; Noguerol KR; León CS
    Prep Biochem Biotechnol; 2004 Aug; 34(3):227-37. PubMed ID: 15461139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the diagnostic value of recombinant antigens and synthetic peptides that mimic the immunogenic epitopes of the envelop protein gp41 in the enzyme immunodetection of HIV-1 antibodies].
    Baranova EN; Puzyrev VF; Van'kova OE; Pimenov VK; Burkov AN; Obriadina AP; Ulanova TI
    Vopr Virusol; 2006; 51(3):46-8. PubMed ID: 16826757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitope-vaccines: a new strategy to induce high levels of neutralizing antibodies against HIV-1.
    Xiao Y; Liao M; Lu Y; Dierich MP; Chen YH
    Immunobiology; 2000 Jan; 201(3-4):323-31. PubMed ID: 10776789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunosuppressive peptide of HIV-1 gp41 like human type I interferons up-regulates MHC class I expression on H9 and U937 cells.
    Chen YH; Xiao Y; Wu W; Zhao Y; Speth C; Dierich MP
    Immunol Lett; 1997 Nov; 59(2):93-7. PubMed ID: 9373217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrete regions of HIV-1 gp41 defined by syncytia-inhibiting affinity-purified human antibodies.
    Vanini S; Longhi R; Lazzarin A; Vigo E; Siccardi AG; Viale G
    AIDS; 1993 Feb; 7(2):167-74. PubMed ID: 7682083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the mechanism of complement-mediated inhibition of antibody binding to HIV gp41.
    Hidvégi T; Prohászka Z; Ujhelyi E; Thielens NM; Dierich MP; Hampl H; Arlaud G; Nagy K; Füst G
    Clin Exp Immunol; 1993 Dec; 94(3):490-3. PubMed ID: 8252810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cell epitope mapping of human immunodeficiency virus envelope glycoproteins with long (19- to 36-residue) synthetic peptides.
    Neurath AR; Strick N; Lee ES
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():85-95. PubMed ID: 1689372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quaternary protein mimetics of gp41 elicit neutralizing antibodies against HIV fusion-active intermediate state.
    Sadler K; Zhang Y; Xu J; Yu Q; Tam JP
    Biopolymers; 2008; 90(3):320-9. PubMed ID: 18338371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV neutralizing IgA in exposed seronegative subjects recognise an epitope within the gp41 coiled-coil pocket.
    Pastori C; Barassi C; Piconi S; Longhi R; Villa ML; Siccardi AG; Clerici M; Lopalco L
    J Biol Regul Homeost Agents; 2000; 14(1):15-21. PubMed ID: 10763886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunodominant glycoprotein 41 epitope identified by seroreactivity in HIV type 1-infected individuals.
    Calarota S; Jansson M; Levi M; Broliden K; Libonatti O; Wigzell H; Wahren B
    AIDS Res Hum Retroviruses; 1996 May; 12(8):705-13. PubMed ID: 8744581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.